Cargando…
Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma
Our pathological study of a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma suggested that immune checkpoint inhibitor may be an effective therapy. The histological type is an important factor in determining treatment choices.
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428809/ https://www.ncbi.nlm.nih.gov/pubmed/34522383 http://dx.doi.org/10.1002/ccr3.4764 |
| _version_ | 1783750444106907648 |
|---|---|
| author | Omori, Ginji Osuga, Takahiro Miyanishi, Koji Hamaguchi, Kota Tanaka, Shingo Ohnuma, Hiroyuki Murase, Kazuyuki Takada, Kohichi Nagayama, Minoru Kimura, Yasutoshi Takemasa, Ichiro Kikuchi, Yasuhiro Torigoe, Toshihiko Kato, Junji |
| author_facet | Omori, Ginji Osuga, Takahiro Miyanishi, Koji Hamaguchi, Kota Tanaka, Shingo Ohnuma, Hiroyuki Murase, Kazuyuki Takada, Kohichi Nagayama, Minoru Kimura, Yasutoshi Takemasa, Ichiro Kikuchi, Yasuhiro Torigoe, Toshihiko Kato, Junji |
| author_sort | Omori, Ginji |
| collection | PubMed |
| description | Our pathological study of a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma suggested that immune checkpoint inhibitor may be an effective therapy. The histological type is an important factor in determining treatment choices. |
| format | Online Article Text |
| id | pubmed-8428809 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84288092021-09-13 Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma Omori, Ginji Osuga, Takahiro Miyanishi, Koji Hamaguchi, Kota Tanaka, Shingo Ohnuma, Hiroyuki Murase, Kazuyuki Takada, Kohichi Nagayama, Minoru Kimura, Yasutoshi Takemasa, Ichiro Kikuchi, Yasuhiro Torigoe, Toshihiko Kato, Junji Clin Case Rep Case Reports Our pathological study of a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma suggested that immune checkpoint inhibitor may be an effective therapy. The histological type is an important factor in determining treatment choices. John Wiley and Sons Inc. 2021-09-09 /pmc/articles/PMC8428809/ /pubmed/34522383 http://dx.doi.org/10.1002/ccr3.4764 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Case Reports Omori, Ginji Osuga, Takahiro Miyanishi, Koji Hamaguchi, Kota Tanaka, Shingo Ohnuma, Hiroyuki Murase, Kazuyuki Takada, Kohichi Nagayama, Minoru Kimura, Yasutoshi Takemasa, Ichiro Kikuchi, Yasuhiro Torigoe, Toshihiko Kato, Junji Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma |
| title | Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma |
| title_full | Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma |
| title_fullStr | Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma |
| title_full_unstemmed | Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma |
| title_short | Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma |
| title_sort | programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428809/ https://www.ncbi.nlm.nih.gov/pubmed/34522383 http://dx.doi.org/10.1002/ccr3.4764 |
| work_keys_str_mv | AT omoriginji programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT osugatakahiro programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT miyanishikoji programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT hamaguchikota programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT tanakashingo programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT ohnumahiroyuki programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT murasekazuyuki programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT takadakohichi programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT nagayamaminoru programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT kimurayasutoshi programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT takemasaichiro programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT kikuchiyasuhiro programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT torigoetoshihiko programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma AT katojunji programmedcelldeathligand1expressioninacaseofpoorlydifferentiatedlymphocyterichhepatocellularcarcinoma |